The role of HDAC3 and its inhibitors in regulation of oxidative stress and chronic diseases

被引：26
作者：
He, Ruyuan [1 ]
Liu, Bohao [1 ]
Geng, Boxin [2 ]
Li, Ning [1 ]
Geng, Qing [1 ]
机构：
[1] Wuhan Univ, Dept Thorac Surg, Renmin Hosp, Wuhan, Peoples R China
[2] Army Med Univ, Mil Med Univ 3, Sch Basic Med, Chongqing, Peoples R China
来源：
CELL DEATH DISCOVERY | 2023年 / 9卷 / 01期
基金：
中国国家自然科学基金;
关键词：
HISTONE DEACETYLASE 3; ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE; TRANSCRIPTION FACTORS; PODOCYTE INJURY; DOWN-REGULATION; ACETYLATION; FOXO; MECHANISMS; EXPRESSION;
D O I：
10.1038/s41420-023-01399-w
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
HDAC3 is a specific and crucial member of the HDAC family. It is required for embryonic growth, development, and physiological function. The regulation of oxidative stress is an important factor in intracellular homeostasis and signal transduction. Currently, HDAC3 has been found to regulate several oxidative stress-related processes and molecules dependent on its deacetylase and non-enzymatic activities. In this review, we comprehensively summarize the knowledge of the relationship of HDAC3 with mitochondria function and metabolism, ROS-produced enzymes, antioxidant enzymes, and oxidative stress-associated transcription factors. We also discuss the role of HDAC3 and its inhibitors in some chronic cardiovascular, kidney, and neurodegenerative diseases. Due to the simultaneous existence of enzyme activity and non-enzyme activity, HDAC3 and the development of its selective inhibitors still need further exploration in the future.
引用
收藏
页数：11
相关论文
共 158 条
  • [1] Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy
    Adhikari, Nilanjan
    Jha, Tarun
    Ghosh, Balaram
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (13) : 8827 - 8869
  • [2] An HDAC3-PROX1 corepressor module acts on HNF4α to control hepatic triglycerides
    Armour, Sean M.
    Remsberg, Jarrett R.
    Damle, Manashree
    Sidoli, Simone
    Ho, Wesley Y.
    Li, Zhenghui
    Garcia, Benjamin A.
    Lazar, Mitchell A.
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [3] Reactive oxygen species-mediated cardiac-reperfusion injury: Mechanisms and therapies
    Bagheri, Fereshte
    Khori, Vahid
    Alizadeh, Ali Mohammad
    Khalighfard, Solmaz
    Khodayari, Saeed
    Khodayari, Hamid
    [J]. LIFE SCIENCES, 2016, 165 : 43 - 55
  • [4] Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation
    Bai, Yang
    Wang, Xiaolu
    Zhao, Song
    Ma, Chunye
    Cui, Jiuwei
    Zheng, Yang
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2015, 2015
  • [5] Differential contributions of Caenorhabditis elegans histone deacetylases to Huntingtin polyglutamine toxicity
    Bates, EA
    Victor, M
    Jones, AK
    Shi, Y
    Hart, AC
    [J]. JOURNAL OF NEUROSCIENCE, 2006, 26 (10) : 2830 - 2838
  • [6] Renal Inflammation and Fibrosis: A Double-edged Sword
    Black, Laurence M.
    Lever, Jeremie M.
    Agarwal, Anupam
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2019, 67 (09) : 663 - 681
  • [7] Biologics and their delivery systems: Trends in myocardial infarction
    Borrelli, Matthew A.
    Turnquist, Heth R.
    Little, Steven R.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2021, 173 : 181 - 215
  • [8] Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
    Brunet, A
    Sweeney, LB
    Sturgill, JF
    Chua, KF
    Greer, PL
    Lin, YX
    Tran, H
    Ross, SE
    Mostoslavsky, R
    Cohen, HY
    Hu, LS
    Cheng, HL
    Jedrychowski, MP
    Gygi, SP
    Sinclair, DA
    Alt, FW
    Greenberg, ME
    [J]. SCIENCE, 2004, 303 (5666) : 2011 - 2015
  • [9] The FoxO code
    Calnan, D. R.
    Brunet, A.
    [J]. ONCOGENE, 2008, 27 (16) : 2276 - 2288
  • [10] The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors
    Cao, Fangyuan
    Zwinderman, Martijn R. H.
    Dekker, Frank J.
    [J]. MOLECULES, 2018, 23 (03):
12345678910